Aerobic Exercise in Patients Receiving Chemotherapy for Cancer
Stopped early · Not applicable
Conditions studied: Cardiac Toxicity, Chemotherapeutic Agent Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Aerobic exercise may help prevent side effects caused by chemotherapy and help improve heart health. PURPOSE: This randomized clinical trial is studying the side effects of aerobic exercise and to see how well it works in patients receiving chemotherapy for cancer.
Key facts
- Study ID
- NCT00728429
- Run by
- Wake Forest University Health Sciences
- People needed
- 1
- Starts
- 2008-06-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2017-05-30
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.